Douglas Errington

543 citations
5 papers · 406 indexed · h-index 4
Topics
Cancer Diagnosis and Treatment (2 papers)Ocular Oncology and Treatments (2 papers)Breast Cancer Treatment Studies (1 paper)
Partner nations
United Kingdom

In The Last Decade

Douglas Errington

5 papers receiving 399 citations

Peers

Douglas Errington
Comparison fields: 5 of 53
  • Otorhinolaryngology 243
  • Surgery 153
  • Oncology 119
  • Periodontics 90
  • Pulmonary and Respiratory Medicine 82
Replace Milovan Dimitrijević with:
Milovan Dimitrijević Serbia
Janjira Petsuksiri Thailand
Toshimichi Yasui Japan
Célia M. Viégas Brazil
P.J. Kreinbrink United States
Keith Kwan Canada
Vidhya Karivedu United States
M.M. Rietbergen Netherlands
Weiming Cai China
Amanda‐Louise Fenger Carlander Denmark
Douglas Errington relative to Milovan Dimitrijević Serbia Milovan Dimitrijević's profile →
Citations per field
00.5×1.5×2.4×
Milovan Dimitrijević · 1×
Citations per year

Countries citing papers authored by Douglas Errington

Since Specialization
Citations

This map shows the geographic impact of Douglas Errington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Errington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Errington more than expected).

Fields of papers citing papers by Douglas Errington

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas Errington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Errington. The network helps show where Douglas Errington may publish in the future.

Co-authorship network of co-authors of Douglas Errington

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas Errington. A scholar is included among the top collaborators of Douglas Errington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas Errington. Douglas Errington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
#WorkIndexed citations
1 5
2 6
3 3
4 53
5 339

About Douglas Errington

Douglas Errington is a scholar working on Instrumentation, Otorhinolaryngology and Ophthalmology, having authored 5 papers that have together received 406 indexed citations. Recurring topics across this work include Cancer Diagnosis and Treatment (2 papers), Ocular Oncology and Treatments (2 papers) and Breast Cancer Treatment Studies (1 paper). The work is most often cited by research in Otorhinolaryngology (243 citations), Periodontics (90 citations) and Ophthalmology (54 citations). Douglas Errington has collaborated with scholars based in United Kingdom. Frequent co-authors include Derek Lowe, David Sutton, James S. Brown, Richard Shaw, Patrick Magennis, S.N. Rogers, David Vaughan, Julia A. Woolgar, I G Rennie and Sachin M. Salvi. Their work appears in journals such as Journal of Clinical Oncology, Oral Oncology and Eye.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026